The reduced level of GD3 in our fascin knockdown cells is consistent with our previous studies, where we demonstrated a fascin-mediated effect on both beta 1 integrin expression [19] and FAK activation [15] in breast cancer cells. The gene discussed is FSCN1; the disease is breast carcinoma.